Enlivex (ENLV) has released an update.
Enlivex Therapeutics Ltd. postponed its Annual General Meeting of Shareholders due to the absence of a quorum, rescheduling it for November 7, 2024. This delay highlights procedural challenges that can impact shareholder engagement and investor confidence. The meeting will take place at the company’s offices in Nes Ziona, Israel.
For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.
